Lung Neoplasms: all 7,333 studies
Page 69 of 74. Open to participants first (1,554), then studies with results posted, then the rest; newest registration first within each.
- Phase 2 Study Of Neoadjuvant Iressa Treatment In Stage 1 NSCLCCompletedNCT00188617Phase 2
- Minimum Dose Computed Tomography of the Thorax for Follow-up in Patients With Resected Lung CarcinomaCompletedNCT00188279Phase 2
- CT Perfusion Scans for Assessment of Lung Cancer Before and After Chemo +/- RadiotherapyCompletedNCT00188214Phase 2
- Sleep Disturbance in Lung Cancer Patients.Status unknownNCT00187980
- Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung CancersCompletedNCT00185913
- Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.WithdrawnNCT00184288
- Characterization of Brain MetastasesCompletedNCT00184275
- Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00182806Phase 2
- Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients.CompletedNCT00181545Phase 1
- Radiofrequency Ablation of Lung TumorsCompletedNCT00180856Phase 2
- Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PETCompletedNCT00180154
- Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung CancerTerminatedNCT00179699Phase 1
- A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung CancerCompletedNCT00179686Phase 2
- Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic TumorsStatus unknownNCT00178698Phase 2
- Circulating Cytokines as Predictors of Radiation Induced Pulmonary ToxicityCompletedNCT00178230
- Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00176137Phase 3
- A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide)CompletedNCT00175747Phase 2/3
- Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00174772Phase 2
- GILT Docetaxel - Non-Small Cell Lung CancerCompletedNCT00174629Phase 3
- Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00173888Phase 2
- Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung CancerCompletedNCT00173875Phase 2
- Methylation Status of CD44 Promoter Region in Primary Lung CancerStatus unknownNCT00173680
- PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC)Status unknownNCT00173524
- Differentiation of Malig. & Ben. Solitary Pulm. Nodules & Prediction of Clin. Outcome Using Perfus. Analysis of DCEMRIStatus unknownNCT00172575
- Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)Status unknownNCT00168922Phase 2
- A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease StageStatus unknownNCT00168896Phase 2/3
- Cetuximab and Vinorelbine in Elderly Subjects With Lung CancerCompletedNCT00165334Phase 2
- Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression ProfilingTerminatedNCT00161278Phase 2
- Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung CancerCompletedNCT00160069Phase 2
- Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer.CompletedNCT00160043Phase 2
- Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLCCompletedNCT00156286Phase 2
- SERPIN D1 and Its Role in Lung Cancer Invasion and MetastasisStatus unknownNCT00155116
- Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00154739Phase 2
- Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung CancerStatus unknownNCT00150657Phase 2
- Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00148291Phase 3
- A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLCCompletedNCT00144989Phase 3
- A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung CancerCompletedNCT00144066Phase 3
- A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung CancerCompletedNCT00144053Phase 3
- Acupuncture for Post-Thoracotomy PainCompletedNCT00142532Phase 3
- Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung CancerStatus unknownNCT00139971Phase 3
- Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer PatientsCompletedNCT00137800Phase 2
- PET Imaging in Potentially Surgically Resectable Non-small Cell Lung CancersCompletedNCT00136890Phase 3
- Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)CompletedNCT00136864Phase 3
- Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301)CompletedNCT00132665Phase 3
- Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00132639Phase 2
- EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given CyclophosphamideCompletedNCT00132522Phase 1
- Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung CancerCompletedNCT00132054Phase 1
- Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung CancerCompletedNCT00129844Phase 2
- Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic CancerCompletedNCT00128622Phase 1
- Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors (JCOG 9806)CompletedNCT00128037Phase 2
- Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and CachexiaTerminatedNCT00127387Phase 2/3
- Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected CancerCompletedNCT00123760Phase 2/3
- Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung CancerCompletedNCT00123747Phase 2
- Study of Motexafin Gadolinium and Docetaxel for Advanced CancerCompletedNCT00120939Phase 1
- Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to ChemotherapyCompletedNCT00120679Phase 2
- A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin AlfaCompletedNCT00119613Phase 3
- EUS-FNA in the Pre-Operative Evaluation of Patients With Lung CancerCompletedNCT00119470Phase 2
- Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung CancerCompletedNCT00118235Phase 2
- Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00118183Phase 2
- Picoplatin as Second-Line Therapy for Patients With Small Cell Lung CancerCompletedNCT00116610Phase 2
- Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During ChemotherapyCompletedNCT00115206Phase 4
- Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00114192Phase 2
- Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00112710Phase 3
- Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung CancerCompletedNCT00112346Phase 2
- A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT00112060Phase 1/2
- Celecoxib Treatment for Lung CancerWithdrawnNCT00108186Phase 1
- Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.CompletedNCT00107432Phase 2
- AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)CompletedNCT00107250Phase 1
- Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung CancerCompletedNCT00104793Phase 2
- Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerStatus unknownNCT00104780Phase 2
- Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00104767Phase 1
- Liposomal SN-38 in Treating Patients With Small Cell Lung CancerWithdrawnNCT00104754Phase 2
- Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung CancerCompletedNCT00103831Phase 1/2
- Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00103389Phase 2
- Sputum Cytology in Screening Heavy Smokers For Lung CancerCompletedNCT00103363Phase 2
- Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung CancerCompletedNCT00103051Phase 2
- A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00102505Phase 1
- ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT00101920Phase 2
- Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerCompletedNCT00101348Phase 1/2
- Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00100854Phase 2
- Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung CancerTerminatedNCT00099879Phase 2
- Non-small Cell Lung Cancer RegistryCompletedNCT00099541Phase 4
- Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung CancerTerminatedNCT00098917Phase 1
- Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00098540Phase 2
- Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung CancerWithdrawnNCT00098462Phase 1/2
- Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung CancerCompletedNCT00098085Phase 2
- Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00097227Phase 2
- Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00097214Phase 2
- A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)CompletedNCT00095225Phase 2
- Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00094822
- Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous RadiotherapyTerminatedNCT00093132Phase 1/2
- Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung CancerCompletedNCT00092001Phase 2
- A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00091663Phase 3
- Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTerminatedNCT00091156Phase 3
- Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With SurgeryCompletedNCT00091039Not applicable
- S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung CancerTerminatedNCT00090961Not applicable
- A Phase 2, Open-Label, Multicenter Study of the GARFT Inhibitor in Patients With Metastatic Non-Small Cell Lung CancerWithdrawnNCT00090701Phase 2
- A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00089726Phase 2
- Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung CancerCompletedNCT00089310Not applicable
- Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00088959Phase 1